×

Loading...
Ad by
  • 推荐 OXIO 加拿大高速网络,最低月费仅$40. 使用推荐码 RCR37MB 可获得一个月的免费服务
Ad by
  • 推荐 OXIO 加拿大高速网络,最低月费仅$40. 使用推荐码 RCR37MB 可获得一个月的免费服务

果然厉害Fig. 5. Identification and characterization of a broadly neutralizing...

Download scientific diagram | Identification and characterization of a broadly neutralizing monoclonal antibody from Smg immunized mice. a, FACS showing the percentage of spike-specific B cells from mice immunized with Sfg or Smg at day 28 after the last immunization. b, The relative ratio of the percentage of S-specific B cells (CD3 − CD19 + S + ) vs. negative staining (without S) in the spleen of immunized mice or naïve mice (n=5). c, FACS analysis of m31A7 binding with 293T cells expressing S protein of WH01 and various variants. d, ELISA showing m31A7 binding to S1, S2, or RBD of the S protein. from publication: Impact of Glycosylation on SARS-CoV-2 Infection and Broadly Protective Vaccine Design | A major challenge to end the pandemic caused by SARS-CoV-2 is to develop a broadly protective vaccine. As the key immunogen, the spike protein is frequently mutated with conserved epitopes shielded by glycans. Here, we reveal that spike glycosylation has site-differential... | Vaccine Development, COVID-19 and Protection | ResearchGate, the professional network for scientists.
Report

Replies, comments and Discussions:

  • 枫下家园 / 医药保健 / 好消息!台湾中研院已经开发出了广效疫苗,对所有变种都有效。不想打mRNA的等一等很快就有真正的疫苗了。春天快了!
    • 有效性本来就问题不大,关键是有效期 +1
      • 现在的mRNA疫苗对omicron是无效的。最早三月辉瑞和莫德纳才能推出新的疫苗对付这个变种。如果有新变种,mRNA会再次失效,这是它的原理决定的。 +2
        • 你被反疫苗人士成功洗脑了 +2
          • 😄
    • 這個研究計劃的主持人, 翁啓惠,目前是諾貝爾化學獎呼聲非常高的候選人,諾獎的所有預備奬, 翁啓惠已經全部囊括,是非常有實力的研究人員


      :

      • 果然厉害Fig. 5. Identification and characterization of a broadly neutralizing...
        Download scientific diagram | Identification and characterization of a broadly neutralizing monoclonal antibody from Smg immunized mice. a, FACS showing the percentage of spike-specific B cells from mice immunized with Sfg or Smg at day 28 after the last immunization. b, The relative ratio of the percentage of S-specific B cells (CD3 − CD19 + S + ) vs. negative staining (without S) in the spleen of immunized mice or naïve mice (n=5). c, FACS analysis of m31A7 binding with 293T cells expressing S protein of WH01 and various variants. d, ELISA showing m31A7 binding to S1, S2, or RBD of the S protein. from publication: Impact of Glycosylation on SARS-CoV-2 Infection and Broadly Protective Vaccine Design | A major challenge to end the pandemic caused by SARS-CoV-2 is to develop a broadly protective vaccine. As the key immunogen, the spike protein is frequently mutated with conserved epitopes shielded by glycans. Here, we reveal that spike glycosylation has site-differential... | Vaccine Development, COVID-19 and Protection | ResearchGate, the professional network for scientists.
        • 已經拿到美國的專利,不採用易變異的棘突蛋白特徵,而用專利技術,採用聚醣下面所覆蓋的部分,既不異變異,且能露出更多可供辨認的特徵,能夠讓疫苗產生數量更多且更多樣化的抗體 +2
          • 药不让申请专利吧
            • 藥物專利各國都有,美國藥物專利甚至分化學藥物和生物藥物
      • 留有余地,前几个月台湾就研发高效的单抗株,但后来就没啥动静了 +1
        • 7月宣布的是同一個東西, 單醣化蛋白 +1
      • 美国这次犯的最大错误就是轻视了台湾
        • 拿了美國專利,才正式在上月底公布,會不會用在新冠難說,但是應該會是下一代流行性病毒疫苗主力,台灣已經有高端的次蛋白疫苗在聯合國等3期結果 +3
    • 历害国马上也会宣称开发出新疫苗。哈哈 +1
      • 啥意思?你以为台湾这个也是骗子? +2
        • 就是个骗子 +8
          • 你啥毛病? +2